enprofylline has been researched along with Spinal Cord Injuries in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nantwi, KD | 1 |
| Goshgarian, HG | 1 |
1 other study available for enprofylline and Spinal Cord Injuries
| Article | Year |
|---|---|
Alkylxanthine-induced recovery of respiratory function following cervical spinal cord injury in adult rats.
Topics: Animals; Bronchodilator Agents; Cervical Vertebrae; Diaphragm; Dose-Response Relationship, Drug; Fem | 2001 |